Latest news out of #ASCO22; GSK, Bristol Myers get M&A going in vaccines, oncology; Roche's pact spotlights new cancer target; and more
Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add Endpoints Weekly. New to Endpoints? Sign up here.
We have a stream of ASCO news coming out of Chicago this weekend, with Kyle LaHucik reporting on site and Lei Lei Wu bringing the news and analysis virtually. Be sure to check the home page from time to time for any new stories.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 144,400+ biopharma pros reading Endpoints daily — and it's free.